Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-08T01:20:27.407Z Has data issue: false hasContentIssue false

4 - Processing of Pleural and Peritoneal Pathologic Specimens for the Diagnosis of Malignant Mesothelioma

Published online by Cambridge University Press:  16 March 2018

By
Françoise Galateau-Sallé
Edited by
Alberto M. Marchevsky ,
Aliya N. Husain  and
Françoise Galateau-Sallé
Alberto M. Marchevsky
Affiliation:
Cedars Sinai Medical Center, Los Angeles
Aliya N. Husain
Affiliation:
University of Chicago
Françoise Galateau-Sallé
Affiliation:
MESOPATH National Reference Center & Cancer Center Leon Berard
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Practical Pathology of Serous Membranes , pp. 40 - 52
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

WHO (World Health Organization). WHO classification of tumours of the lung, pleura, thymus and heart. 4th ed. Travis, WD, Brambilla, E, Burke, AP, Marx, A, Nicholson, AG, editors. Lyon: IARC Press; 2015.Google Scholar
Galateau-Sallé, F, Churg, A, Roggli, V, Travis, WD. The 2015 WHO classification of tumors of the pleura: advances since the 2004 classification. J Thoracic Oncol. 2016;11(2):142–54.Google Scholar
Husain, AN, Colby, T, Ordonez, N, Krausz, T, Attanoos, R, Beasley, MB, et al. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2013;137(5):647–67.CrossRefGoogle ScholarPubMed
CAP (College of American Pathologists). Cancer protocols and checklists. 2015. Available from: www.cap.org/cancer-reporting-tools/cancer-reporting templates?afrLoop=5315966824823314#Google Scholar
RCPA (Royal College of Pathologists of Australasia). Structured pathology reporting of cancer protocols. 2010–2015. Available from: www.rcpa.edu.au/Library/Practising-Pathology/Structured-Pathology-Reporting-of-Cancer/Cancer-Protocols.Google Scholar
RCP (Royal College of Pathologists). Datasets and tissue pathways. 2015. Available from: www.rcpath.org/index.asp?PageID=254.Google Scholar
Scherpereel, A, Astoul, P, Baas, P, Berghmans, T, Clayson, H, de Vuyst, P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010;35(3):479–95.CrossRefGoogle ScholarPubMed
Churg, A, Attanoos, R, Borczuck, A, Chirieac, LR, Galateau-Sallé, F, Gibbs, A, et al. Dataset for reporting of malignant mesothelioma of the pleura and peritoneum: recommendations from the International Collaboration on Cancer Reporting (ICCR). Arch Pathol Lab Med. 2016; 140(10):1104–10.Google Scholar
Stahel, RA, Weder, W, Felip, E, ESMO Guidelines Working Group. Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19(Suppl 2):ii43–44.Google Scholar
van Zandwijk, N, Clarke, C, Henderson, D, Musk, AW, Fong, K, Nowak, A, et al. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis. 2013; 5(6):E254–307.Google Scholar
Henderson, WD, Reid, G, Kao, SC, van Zandwijk, N, Klebe, S. Challenges and controversies in the diagnosis of malignant mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia and biomarkers. J Clin Pathol. 2013; 66(10):847–53.Google Scholar
Henderson, WD, Reid, G, Kao, SC, van Zandwijk, N, Klebe, S. Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA. J Clin Pathol. 2013; 66(10):854–61.Google Scholar
Goldberg, M, Imbernon, E, Rolland, P, Gilg, Soit Ilg A, Savès, M, de Quillacq, A, et al. The French National Mesothelioma Surveillance Program. Occup Environ Med. 2006;63(6):390–95.CrossRefGoogle ScholarPubMed
Maskell, NA, Butland, RJ; Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax. 2003;58(Suppl 2):ii8–17.Google Scholar
Du Rand, I, Maskell, N. Introduction and methods: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii1–eii3.Google Scholar
Roberts, ME, Neville, E, Berrisford, RG, Antunes, G, Ali, NJ, BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: BritishThoracic Society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii32–eii40.CrossRefGoogle Scholar
Churg, A, Sheffield, BS, Galateau-Sallé, F. New markers for separating benign from malignant mesothelial proliferations: are we there yet? Arch Pathol Lab Med. 2015;140(4):318–21.Google ScholarPubMed
ATS. Am J Respir Crit Care Med. 2000;162:19872001. Available from: www.atsjournals.orgGoogle Scholar
Egan, AM, McPhillips, D, Sarkar, S, Breen, DP. Malignant pleural effusion. Q J Med. 2014;107(3):179–84.Google Scholar
Cellerin, L, Marcq, M, Sagan, C, Chailleux, E. Pleurésies malignes révélatrices d'un cancer: comparaison des étiologies avec les pleurésies métastatiques. Rev Mal Respir. 2008;25(9):1104–09.Google Scholar
Karoo, RO, Lloyd, TD, Garcea, G, Redway, HD, Robertson, GS. How valuable is ascetic cytology in the detection and management of malignancy. Postgrad Med. 2003;79:292–94.Google Scholar
Motherby, H, Nadjari, B, Friegel, P, Kohaus, J, Bocking, A. Diagnostic accuracy of effusion cytology. Diagn Cytopathol. 1999;20(6):350–57.Google Scholar
Abrams, LD. A pleural-biopsy punch. Lancet. 1958;1:30–31.Google Scholar
Von Hoff, DD, LiVolsi, V. Diagnostic reliability of needle biopsy of the parietal pleura. A review of 272 biopsies. Am J Clin Pathol. 1975;64(2):200–03.Google Scholar
Cagle, PT, Allen, TC. Pathology of the pleura: what the pulmonologists need to know. Respirology. 2011;16(3):430–38. doi: 10.1111/j.1440–1843.2011.01957.x.CrossRefGoogle ScholarPubMed
Cope, C. New pleural biopsy needle. JAMA 1958;167:1107–08.Google Scholar
Tomlinson, JR. Invasive procedures in the diagnosis of pleural disease. Semin Respir Med. 1987;9:30–60.CrossRefGoogle Scholar
Nance, KV, Shermer, RW, Askin, FB. Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination. Mod Pathol. 1991;4:320–24.Google Scholar
Loddenkemper, R, Boutin, C. Thoracoscopy: present diagnostic and therapeutic indications. Eur Respir J. 1993;6:1544–55.Google Scholar
Diacon, AH, Van de Wal, BW, Wyser, C, Smedema, JP, Bezuidenhout, J, Bolliger, CT, et al. Diagnostic tools in tuberculous pleurisy: a direct comparative study. Eur Respir J. 2003;22:589–91.CrossRefGoogle ScholarPubMed
Kirsch, CM, Kroe, DM, Azzi, RL, Jensen, WA, Kagawa, FT, Wehner, JH. The optimal number of pleural biopsy specimens for a diagnosis of tuberculous pleurisy. Chest. 1997;112(3):702–06.CrossRefGoogle ScholarPubMed
Light, RW. Update on tuberculous pleural effusion. Respirology. 2010;15(3):451–58.Google Scholar
Maskell, NA, Gleeson, FV, Davies, RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet. 2003;361(9366):1326–30. PubMed PMID: 12711467.Google Scholar
Dixon, G, de Fonseka, D, Maskell, N. Pleural controversies: image guided biopsy vs. thoracoscopy for undiagnosed pleural effusions? J Thorac Dis. 2015;7(6):1041–51.Google Scholar
Bibby, AC, Maskell, NA. Pleural biopsies in undiagnosed pleural effusions; Abrams vs image-guided vs thoracoscopic biopsies. Curr Opin Pulm Med. 2016;22(4):392–98.Google Scholar
Yang, PC, Kuo, SH, Luh, KT. Ultrasonography and ultrasound guided needle biopsy of chest diseases: indications, techniques, diagnostic yields and complications. J Med Ultrasound. 1993;1:53–63.Google Scholar
Walker, SP, Morley, AJ, Stadon, L, De Fonseka, D, Arnold, DA, Medford, AR, et al. Nonmalignant pleural effusions: a prospective study of 356 consecutive unselected patients. Chest. 2017; 151(5):1099–105. PubMed PMID: 28025056.Google Scholar
Attanoos, RL, Gibbs, AR. The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma. Histopathology. 2008;53(3):340–44. doi: 10.1111/j.1365–2559.2008.03099.x. Epub 2008 Jul 18.)Google Scholar
Boutin, C, Astoul, P. Diagnostic thoracoscopy. Clin Chest Med. 1998;19(2):295–309.Google Scholar
Boutin, C, Schlesser, M, Frenay, C, Astoul, P. Malignant pleural mesothelioa. Eur Respir J. 1998;12:972–81.Google Scholar
Greillier, L, Cavailles, A, Fraticelli, A, Scherpereel, A, Barlesi, F, Tassi, G, et al. Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma. Cancer. 2007;110(10):2248–52.CrossRefGoogle ScholarPubMed
Bueno, R, Reblando, J, Glickman, J, Jaklitsch, MT, Lukanich, JM, Sugarbaker, DJ. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg. 2004; 78(5):1774–76.Google Scholar
Kao, SC, Yan, TD, Lee, K, Burn, J, Henderson, DW, Klebe, S, et al. Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma. J Thorac Oncol. 2011;6(3):602–05.Google Scholar
Rubin, JW, Finney, NR, Borders, BM, Chauvin, EJ. Intrathoracic biopsies, pulmonary wedge excision, and management of pleural disease: is video-assisted closed chest surgery the approach of choice? Am Surg. 1994;60(11):860–63.Google Scholar
Litzky, LA, Gal, A. Lung specimen handling and practical considerations. In: Hasleton, P, Fiedler, DB, editors. Spencer Pathology of the Lung, sixth edition, chapter 2. Cambridge: Cambridge University Press; 2013.Google Scholar
Opitz, I. Management of malignant pleural mesothelioma – the European experience. J Thorac Dis. 2014;6(Suppl 2):S238–52.Google ScholarPubMed
D'Amico, TA, Rocco, G. The biomolecular era for thoracic surgeons: the example of the ESTS Biology Club. J Thorac Dis. 2014;6(Suppl 2):S265–71.Google Scholar
Nowak, AK, Chansky, K, Rice, DC, Pass, HI, Kindler, HL, Shemanski, L, et al. The IASLC Mesothelioma Staging Project: proposals for revisions of the T descriptors in the forthcoming eighth edition of the TNM Classification for Pleural Mesothelioma. J Thorac Oncol. 2016;11(12):2089–99.Google Scholar
Rice, D, Chansky, K, Nowak, A, Pass, H, Kindler, H, Shemanski, L, et al. The IASLC Mesothelioma Staging Project: proposals for the M descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for Mesothelioma. J Thorac Oncol. 2016;11(12):2100–11.Google Scholar
Rusch, VW, Chansky, K, Kindler, HL, Nowak, AK, Pass, HI, Rice, DC, et al. The IASLC Mesothelioma Staging Project: proposals for revisions of the N descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma. J Thorac Oncol. 2016;11(12):2112–19.Google Scholar
Pass, H, Giroux, D, Kennedy, C, Ruffini, E, Cangir, AK, Rice, D, et al. The IASLC Mesothelioma Staging Project: improving staging of a rare disease through international participation. J Thorac Oncol. 2016;11(12):2082–88.Google Scholar
Pillai, K, Pourgholami, MH, Chua, TC, Morris, DL. Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma. Am J Clin Oncol. 2015;38(4):388–94.CrossRefGoogle ScholarPubMed
Engel, KB, Moore, H. Effects of pre analytical variables on the detection of proteins by immunohistochemistry in formalin fixed paraffin embedded tissue. Archiv Pathol Lab Med. 2011;135:537–43.Google Scholar
Khoury, T. Delay to formalin fixation alters morphology and immunohistochemistry for breast carcinoma. Appl Immunohistochem Mol Morphol. 2012;20(6):531–42. PubMed PMID: 22495358.Google Scholar
Khoury, T, Sait, S, Hwang, H, Chandrasekhar, R, Wilding, G, Tan, D, et al. Delay to formalin fixation effect on breast biomarkers. Mod Pathol. 2009;22(11):1457–67. PubMed PMID: 19734848.Google Scholar
Lightfoote, MM, Ball, DJ, Hannon, WH, Ridderhoh, JC, Vogt, RF. Quality assurance for design control and implementation of immunohistochemistry assays; approved guideline. 2nd edition. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI); 2010.Google Scholar
Righi, L, Duregon, E, Vatrano, S, Izzo, S, Giorcelli, J, Rondón-Lagos, M, et al. BRCA1-associated protein 1 (Bap1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification: a large retrospective study. J Thorac Oncol. 2016;11(11):2006–17.Google Scholar
Hwang, HC, Pyott, S, Rodriguez, S, Cindric, A, Carr, A, Michelsen, C, et al. BAP1 immunohistochemistry and p16 FISH in the diagnosis of sarcomatous and desmoplastic mesotheliomas. Am J Surg Pathol. 2016;40(5):714–18.Google Scholar
Sheffield, BS, Hwang, HC, Lee, AF, Thompson, K, Rodriguez, S, Tse, CH, et al. BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations. Am J Surg Pathol. 2015;39(7):977–82.Google Scholar
Singhi, AD, Krasinskas, AM, Chourdy, HA, Bartlett, DL, Pingpank, JF, Zeh, HJ, et al. The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma. Mod Pathol. 2016;29(1):14–24.Google Scholar
Sheffield, BS, Lorette, J, Shen, Y, Marra, MA, Churg, A. Immunohistochemistry for NF2, LATS1/2, and YAP/TAZ fails to separate benign from malignant mesothelial proliferations. Arch Pathol Lab Med. 2016;140(5):391.Google Scholar
Grillo, F, Pigozzi, S, Ceriolo, P, Calamaro, P, Fiocca, R, Mastracci, L. Factors affecting immunoreactivity in long-term storage of formalin-fixed paraffin-embedded tissue sections. Histochem Cell Biol. 2015;144(1):93–99.Google Scholar
Bueno, R, Stawiski, EW, Goldstein, LD, Durinck, S, De Rienzo, A, Modrusan, Z, et al. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet. 2016;48(4):407–16.Google Scholar
Hynes, SO, Pang, B, James, JA, Maxwell, P, Salto-Tellez, M. Tissue-based next generation sequencing: application in a universal healthcare system. Br J Cancer. 2017;116(5):553–60. PubMed PMID: 28103613Google Scholar
Cree, IA, Deans, Z, Ligtenberg, MJ, Normanno, N, Edsjö, A, Rouleau, E, et al. Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol. 2014;67(11):923–31.Google Scholar
Deans, ZC, Costa, JL, Cree, I, Dequeker, E, Edsjö, A, Henderson, S, et al. Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL.Virchows Arch. 2017;470(1):5–20.Google Scholar
Aziz, N, Zhao, Q, Bry, L, Driscoll, DK, Funke, B, Gibson, JS, et al. College of American Pathologists’ laboratory standards for next-generation sequencing clinical tests. Arch Pathol Lab Med. 2015;139(4):481–93.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×